Evidence map›Paper›PMID 37747493›Full record

ArticleUrologie (Heidelberg, Germany)2024

[Urinary incontinence after radical prostatectomy for prostate cancer-data from 17,149 patients from 125 certified centers].

Christoph Kowalski, Nora Tabea Sibert, Peter Hammerer, Simone Wesselmann, Günter Feick, Ernst-Günther Carl, Theodor Klotz, Hendrik Apel, Sebastian Dieng, Joanne Nyarangi-Dix and 41 more

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Urologie (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. [Male slings-an overview].Urologie (Heidelberg, Germany) · 2026
    Review
  2. Article
  3. [Active surveillance of prostate cancer].Urologie (Heidelberg, Germany) · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

51 authors at 20 institutions in 3 countries.

Christoph KowalskiDeutsche Krebsgesellschaft, Berlin, Kuno-Fischer-Str. 8, 14057, Berlin, Deutschland. kowalski@krebsgesellschaft.de.
Nora Tabea SibertDeutsche Krebsgesellschaft, Berlin, Kuno-Fischer-Str. 8, 14057, Berlin, Deutschland.
Peter HammererStädtisches Klinikum Braunschweig, Braunschweig, Deutschland.
Simone WesselmannDeutsche Krebsgesellschaft, Berlin, Kuno-Fischer-Str. 8, 14057, Berlin, Deutschland.
Günter FeickBundesverband Prostatakrebs Selbsthilfe, Bonn, Deutschland.
Ernst-Günther CarlBundesverband Prostatakrebs Selbsthilfe, Bonn, Deutschland.
Theodor KlotzKliniken Nordoberpfalz, Weiden, Deutschland.
Hendrik ApelUniklinikum Erlangen, Erlangen, Deutschland.
Sebastian DiengOnkoZert, Neu-Ulm, Deutschland.
Joanne Nyarangi-DixHegau-Bodensee-Klinikum Singen, Singen, Deutschland.
Thomas KnollKlinikum Sindelfingen-Böblingen, Sindelfingen, Deutschland.
Moritz Johannes ReikeMarien Hospital Herne, Ruhr-Universität Bochum, Herne, Deutschland.
Gregor DuweKlinik und Poliklinik für Urologie und Kinderurologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
Elisabeth BartolfKlinikum Ingolstadt, Ingolstadt, Deutschland.
Thomas SteinerHelios Klinikum Erfurt, Erfurt, Deutschland.
Rainer BorowitzKlinikum Memmingen, Memmingen, Deutschland.
Gerd LümmenGFO Kliniken Troisdorf, Troisdorf, Deutschland.
Anna Katharina SeitzKlinik und Poliklinik für Urologie und Kinderurologie, Universitätsklinikum Würzburg, Würzburg, Deutschland.
Jesco PfitzenmaierEv. Klinikum Bethel, Universitätsklinikum OWL d, Universität Bielefeld, Bielefeld, Deutschland.
Atiqullah AzizMünchen Klinik Bogenhausen, Bogenhausen, Deutschland.
Marko BrockStiftungsklinikum PROSELIS Recklinghausen, Recklinghausen, Deutschland.
Frank Peter BergerKlinik für Urologie, Universitätsklinikum Jena, Jena, Deutschland.
Björn Theodor KaftanKlinikum Lüneburg, Lüneburg, Deutschland.
Christian GrubeKlinikum Magdeburg, Magdeburg, Deutschland.
Tim HäfnerUniversitätsklinikum Leipzig, Leipzig, Deutschland.
Amir HamzaKlinikum St. Georg Leipzig, Leipzig, Deutschland.
Hans SchmelzBundeswehrZentralkrankenhaus Koblenz, Koblenz, Deutschland.
Jürgen HaasKlinikum am Steinenberg, Reutlingen, Deutschland.
Sebastian LenartBarmherzige Brüder Krankenhaus Wien, Wien, Österreich.
Anselm LafitaInselspital Bern, Bern, Schweiz.
Carsten SippelKlinikum Friedrichshafen, Friedrichshafen, Deutschland.
Alexander WinterUniversitätsklinik für Urologie, Klinikum Oldenburg, Department für Humanmedizin, Fakultät für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg, Oldenburg, Deutschland.
George KediaDIAKOVERE Friederikenstift, Hannover, Deutschland.
Boris HadaschikUniversitätsklinikum Essen, Essen, Deutschland.
Zoltan VargaSRH Kliniken Landkreis Sigmaringen, Sigmaringen, Deutschland.
Stephan BuseAlfried Krupp Krankenhaus, Essen, Deutschland.
Matthias RichterKliniken Maria Hilf Mönchengladbach, Mönchengladbach, Deutschland.
Florian DistlerUniversitätsklinik der Paracelsus, Privatuniversität am Klinikum Nürnberg, Nürnberg, Deutschland.
Jörg SimonOrtenau-Klinikum Offenburg, Offenburg, Deutschland.
Thomas WiegelUniversitätsklinikum Ulm, Ulm, Deutschland.
Stefan BaltesKlinikum Region Hannover, Hannover, Deutschland.
Andreas JanitzkyUniversitätsklinikum Magdeburg, Magdeburg, Deutschland.
Jens Peter SommerRems-Murr-Klinikum Winnenden, Winnenden, Deutschland.
Sameh HijaziKlinikum Ibbenbüren, Ibbenbüren, Deutschland.
Philipp FülkellUniversitätsklinikum Greifswald, Greifswald, Deutschland.
Nina N HarkeMedizinische Hochschule Hannover, Hannover, Deutschland.
Christian BolenzUniversitätsklinikum Ulm, Ulm, Deutschland.
Christian KhalilJohanniter Krankenhaus Oberhausen, Oberhausen, Deutschland.
Clara BreidenbachDeutsche Krebsgesellschaft, Berlin, Deutschland.
Pierre TennstedtMartini Klinik am Universitätsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Deutschland.
Martin BurchardtUniversitätsklinikum Greifswald, Greifswald, Deutschland.
Bundesverband Glaukom-Selbsthilfe · DEFischer (Germany) · DEGerman Cancer Society · DEKlinikum Magdeburg · DEUniversitätsmedizin Greifswald · DEUniversity Hospital Ulm · DEAlbstadt-Sigmaringen University · DEAlfried Krupp Hospital · DEBarmherzige Schwestern Krankenhaus Wien · ATBG Klinikum Hamburg · DEBielefeld University · DEBundeswehrzentralkrankenhaus Koblenz · DECarl von Ossietzky Universität Oldenburg · DEEssen University Hospital · DEEvangelisches Krankenhaus Oberhausen · DEHegau-Bodensee-Klinikum Singen · DEHelios Klinikum Erfurt · DEJena University Hospital · DEJohannes Gutenberg University Mainz · DEKernkraftwerk Gundremmingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn addition to erectile dysfunction, urinary incontinence is the most common functional limitation after radical prostatectomy (RPE) for prostate cancer (PCa). The German S3 guideline recommends informing patients about possible effects of the therapy options, including incontinence. However, only little data on continence from routine care in German-speaking countries after RPE are currently available, which makes it difficult to inform patients.

objectiveThe aim of this work is to present data on the frequency and severity of urinary incontinence after RPE from routine care. MATERIALS AND

methodsInformation from the PCO (Prostate Cancer Outcomes) study is used, which was collected between 2016 and 2022 in 125 German Cancer Society (DKG)-certified prostate cancer centers in 17,149 patients using the Expanded Prostate Cancer Index Composite Short Form (EPIC-26). Changes in the "incontinence" score before (T0) and 12 months after RPE (T1) and the proportion of patients who used pads, stratified by age and risk group, are reported.

resultsThe average score for urinary incontinence (value range: 0-worst possible to 100-best possible) was 93 points at T0 and 73 points 12 months later. At T0, 97% of the patients did not use a pad, compared to 56% at T1. 43% of the patients who did not use a pad before surgery used at least one pad a day 12 months later, while 13% use two or more. The proportion of patients using pads differs by age and risk classification.

conclusionThe results provide a comprehensive insight into functional outcome 12 months after RPE and can be taken into account when informing patients.

Indexed as

Erectile DysfunctionProstatic NeoplasmsUrinary IncontinenceHumansMaleProstatectomyCertified CenterEPIC-26Functional outcomeQuality of lifeRoutine Practice Data

Identifiers

PMID37747493
OpenAlexW4387002679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.